Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact email@example.com.
Assessing COVID-19 Vaccine Hesitancy, Confidence and Public Engagement: A Global Social Listening Study
20 Pages Posted: 29 Jan 2021More...
Background: To assess global hesitancy, confidence and public engagement towards COVID-19 vaccination.
Methods: We collected and manually coded 12886 social media posts mentioning COVID-19 vaccine from five global metropolises with high COVID-19 burden between June and July, 2020. After assessment, 7032 posts were included in analysis. We manually double-coded these posts using a coding framework developed according to the WHO’s Confidence, Complacency, and Convenience model of vaccine hesitancy, and conducted engagement analysis to investigate public communication about COVID-19 vaccine on social media.
Findings: Among social media users, 36.4% (571/1568) in New York, 51.3% (738/1440) in London, 67.3% (144/214) in Sao Paulo, 69.8% (726/1040) in Mumbai, and 76.8% (2128/2770) in Beijing indicated that they intended to accept COVID-19 vaccination. With high perceived risk of getting COVID-19, more tweeters in New York and London expressed lack of confidence in vaccine safety, distrust in governments and experts, and widespread misinformation and rumors. Tweeters from Mumbai, Sao Paulo and Beijing worried more about vaccine production and supply, whereas tweeters from New York and London had more concern on vaccine distribution and inequity. Negative tweets expressing lack of vaccine confidence and misinformation or rumors, had more followers and attracted more public engagement online.
Interpretation: COVID-19 vaccine hesitancy is prevalent across the world, and negative tweets attract higher engagement on social media. It is urgent to develop an effective vaccine campaign that boosts public confidence and addresses hesitancy for COVID-19 vaccine rollout.
Funding: National Natural Science Foundation of China (No. 71874034).
Declaration of Interests: We declare no competing interests.
Ethics Approval Statement: This study was exempt from ethical review because it examined retrospective, publicly-available data.
Keywords: COVID-19 vaccine, hesitancy, confidence, acceptance, engagement.
Suggested Citation: Suggested Citation